ArticleCurrent microbiology2021
Complete Genome Sequence of Zearalenone Degrading Bacteria Bacillus velezensis A2.
Article in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- Bacillus velezensis CL197: a zearalenone detoxifying strain isolated from wheat with potential to be used in animal production.Veterinary research communications · 2024Article
- Comparative genomic and transcriptome analysis of Bacillus velezensis CL-4 fermented corn germ meal.AMB Express · 2023Article
- Excavation, expression, and functional analysis of a novel zearalenone-degrading enzyme.Folia microbiologica · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zearalenone (ZEN) is a severe contaminant mycotoxin found worldwide. Our previous results indicate that Bacillus velezensis A2 isolated from ZEN-contaminated crop soil can degrade ZEN. Here, we present the complete genomic sequence of B. velezensis A2 (the Genbank accession number: CP053717), which contains 3,929,218 bp in the chromosome, has a GC content of 46.5%, and contains the encoded ZEN-degrading enzyme gene. The complete genomic sequence can provide a genomic basis for a series of A2 biotechnology applications as an effective method of degrading ZEN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.